Concizumab Biosimilar – Anti-TFPI mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameConcizumab Biosimilar - Anti-TFPI mAb - Research Grade
SourceCAS 1312299-39-0
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsConcizumab,Anti-TFPI,NN7415,mab2021,TFPI,anti-TFPI
ReferencePX-TA1306
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Concizumab Biosimilar - Anti-TFPI mAb - Research Grade

General information on Anti-TFPI[Homo sapiens] (Concizumab) Monoclonal Antibody

Concizumab has been investigated for the treatment of Haemophilia A and Congenital Bleeding Disorder.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Concizumab Biosimilar – Anti-TFPI mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

TFPI, N-His, recombinant protein
Antigen

TFPI, N-His, recombinant protein

PX-P5950 385€
Concizumab ELISA Kit
ELISA

Concizumab ELISA Kit

KPTX171 1300€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products